Vaccines Market Research Reports & Industry Analysis

... Global Peptide Vaccine Market & Pipeline Insight” Report Highlights: Introduction & Mechanism of Peptide Vaccine Peptide Vaccine Market Overview Peptide Vaccine Market Dynamics (Drivers, Challenges & Future Outlook) Peptide Vaccine Pipeline by Phase, Indication, Company & Country Peptide Vaccine Pipeline ...

... main drivers to galvanized Influenza vaccines market. Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza vaccines market is expected to grow ... digit percentage from 2013 to 2019. On the other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and ...

Competitor Analysis: Ebola Virus Vaccines and Therapeutics The present Competitive Intelligence Report about prophylaxis and therapy of Ebola virus infections ... Ebola virus infections as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ...

... Ebola Virus Vaccine Market & Pipeline Insight” Report Highlight: Ebola Virus Infection Market Overview Ebola Vaccine Clinical Trial Insight by Phase, Company & Country Ebola Vaccine in Clinical Trials: 26 Vaccine Majority Ebola Vaccine in Preclinical Phase: 15 Vaccines Ebola Vaccines ...

Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins The present Competitive Intelligence Report about prophylaxis and therapy of Rabies ... virus infections as of September 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ...

... Cancer Vaccines Delivery Cancer Vaccines: Mechanism & Innovations Global Cancer Vaccines Clinical Pipeline by Phase, Indication, Company & Country Global Cancer Vaccine Clinical Pipeline: 289 Vaccines Marketed Cancer Vaccines: 12 Vaccines Regulatory Framework for Cancer Vaccines Development & Marketing ...

... (PPV) and other varieties. Since 2011, the bids for compulsory vaccines proposed by the Chinese government has turned to be more fierce, with ... Group, Tecon and Dahuanong with a combined proportion of 15% or so. China Animal Vaccine Industry Report, 2013-2016 by ResearchInChina covers the followings: The ...

... could thus be used as a basis of the vaccine. There are only 2 HPV vaccines which are currently marketed across the globe. Both ... to treat it, either through drugs or through vaccines. “Human Papillomavirus Infections Vaccine Pipeline Analysis” Report Highlights: Human Papillomavirus Vaccine Market Overview ...

... activities and generic competition for off patent products. On the contrary, vaccine segment has developed as highly profitable because of advancements in genomics and ... sales, which thereby allure the market players. The report, “Global Vaccine Market Outlook 2020” provides an extensive research and in-depth ...

... “Global Influenza (Flu) Vaccine Market: Trends and Opportunities (2014-2019)” provides an insight into the market dynamics and various trends and opportunities associated with the global Influenza vaccine market. It covers the global market size and growth dynamics of the influenza vaccine market in past ...

... lines), microorganism-based and others. Of the 140 clinical stage cancer vaccines, three were approved and are commercialized in the major ... . In addition, the report lists company-specific R&D pipelines of cancer vaccines. Competitor projects are listed in a tabular format providing information on: Drug ...

... promising. “HIV Vaccine Market Opportunity & Clinical Pipeline Analysis” Report Highlights: Introduction to HIV Vaccine & Mechanism Global HIV Incidence Scenario R&D Funding Scenario for HIV Vaccine FDA Regulatory Framework HIV Vaccine Clinical Trial by Phase & Country HIV Vaccines in Development Phase ...

... for entry. Constituting almost 50% of the global pie, the US cancer vaccine market was estimated to be worth USD 14 Billion in 2012. With close ... cancer every year, this market is expected to o reach USD 20 billion by 2020. “US Cancer Vaccine Pipeline Analysis” by PNS Pharma gives comprehensive insight on the ...

... sub-divided into four groups namely, pediatrics, adolescents, adults and elderly. Though the vaccines segment forms a very small portion of the ... market is expected to surpass estimated USD 100 billion by 2025. “Global Vaccine Market Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ...

... , proteins, peptides, vaccines and small molecules for prevention and treatment of Staphylococcus aureus infections. In addition, the report lists company-specific R&D pipelines of S. aureus vaccines and therapeutics. Competitor projects are listed in a tabular format providing information on: Drug ...

... West Nile Virus to be used in horses was approved in 2005. 'Global DNA Vaccine Pipeline Analysis' by PNS Pharma gives comprehensive insight on the various ... holders to identify and analyze the available investment opportunity in the DNA vaccine market based upon development process. Following parameters for ...

... (incidence rate: below 1/100,000,000). In 2012, China's lot released volume of measles vaccines reached 8.651 million person-servings, decreasing ... vaccines manufactured by Merck violated the approval process of imported vaccines in China because it lacked alerts in the specification and existed safety risks. ...

... , but the rabies vaccination rate of dogs is less than 10%. Second, China lacks a coordination and management mechanism among departments involving in rabies ... the following information or even more: Development environment of China human rabies vaccines China rabies status overview Supply and demand status ...

... influenza type B is a kind of haemophilus influenza with extremely strong invasiveness. Among all the serious infections caused by haemophilus influenzas, almost 90% were caused by haemophilus influenza type B. According to the researches in recent years, HIB has become the first bacteria that will cause ...

... Type B Haemophilus Influenzae Conjugate Vaccine, Influenza Vaccine, Rabies Vaccine and so on. In China, Vaccine I market are occupied by state-owned enterprises, while foreign- ... market will rise continually. Due to the low vaccination rate in China, there's much space for future growth. With the increase of ...

The Competitive Intelligence Report Anthrax Vaccines & Therapeutics as of June 2013 provides a competitor analysis in the development pipelines of novel vaccines and therapeutics for prophylaxis of Bacillus anthracis infection and treatment of anthrax. Purchase of the pdf report includes a 6-month online ...

... perspective on the actual market situation, trends and future outlook for vaccines in Ireland. The study provides essential market information for decision- ... market study answers to questions such as: What is the size of the vaccine market in Ireland? How is the market divided into different types of products ...

... perspective on the actual market situation, trends and future outlook for vaccines in Panama. The study provides essential market information for decision- ... market study answers to questions such as: What is the size of the vaccine market in Panama? How is the market divided into different types of products? ...

... as: What is the size of the vaccine markets in different countries around the world? How are the markets divided into different types ... Years covered: 2006 - 2017 Countries included in the package: Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belgium, Bolivia, Bulgaria, Canada, Chile, ...

... a perspective on the actual market situation, trends and future outlook for vaccines in Mongolia. The study provides essential market information for decision- ... study answers to questions such as: What is the size of the vaccine market in Mongolia? How is the market divided into different types of products? ...

... a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market ... These market studies answer to questions such as: What is the size of the vaccine markets in top 10 global countries? How are the markets divided into ...

... indicators This market study answers to questions such as: What is the size of the global vaccine market? How is the market divided into different types of products? Which products are growing fast? How the market has been developing? How does the future look like? What is the ...

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different American countries. The studies ... different types of products? Which products are growing fast? How the markets have been developing? How does the future look like? ...

The Competitive Intelligence Report Human Papilloma Virus (HPV) Vaccines & Therapeutics as of May 2013 provides a competitor analysis in the product portfolios and development pipelines of novel vaccines and therapeutics for prophylaxis of HPV infection and HPV-induced neoplasias and treatment of HPV-induced ...

... and operating incomes amidst patent cliffs of blockbuster drugs. In such a scenario, vaccines, which have high entry barriers for generic players and ... with high incidence rates of infectious diseases. The report, “Global Vaccine Market Forecast to 2017” provides an extensive research and in-depth analysis ...

... global management consulting and market research firm, has conducted a competitive analysis of the industry and presents its findings in Global Human Vaccine Industry 2013-2018: Trend, Profit, and Forecast Analysis. North America dominates this industry. India and China are rapidly growing as vaccine production ...

... infect humans. HSV-1 and HSV-2 cause the viral disease herpes simplex which can be categorized into one of several distinct disorders ... . In addition, the report lists company-specific R&D pipelines of Herpes Virus Vaccines & Therapeutics. Competitor projects are listed in a tabular format providing information ...

... Indian Vaccine Industry: Trends and Opportunities (2012-2017) offers in-depth study of the global as well as the Indian vaccine industry with detailed discussion on the major segments of the vaccine industry ...

... , Company, Product Category, Indication, R&D Stage and additional comments with a hyperlink leading to the source of information. About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, ...

... targeting Mycobacterium tuberculosis for prophylaxis and treatment of tuberculosis. In addition, the report lists corporate and public R&D pipelines of Tuberculosis Vaccines & Therapeutics. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action ...

... description The present Competitive Intelligence Report about Malaria Vaccines & Therapeutics provides a competitor evaluation in the field of investigational small molecules and ... regions. Each year more than 350 million new cases of Malaria occur, it is one of the world’s most common diseases. People with ...

... approved for treatment or prevention of CMV disease, such as ganciclovir, or hyperimmune globulin preparations, but no specific CMV vaccine is approved. The present Competitor Analysis describes the R&D pipeline of new molecular entities including vaccines, monoclonal antibodies, peptides, cellular therapy ...

Today Sanofi reported positive proof of efficacy and safety data for tetravalent Dengue vaccine. Although the data supports efficacy, but falls short of winning ... investor’s conviction, as evidence of efficacy was observed only in three out ...

... of Dengue fever and of therapeutics for treatment of Dengue fever. In addition, the report lists company-specific R&D pipelines of Dengue Virus Vaccines & Therapeutics. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of Compound, ...

Competitor Analysis: Respiratory Syncytial Virus (RSV) Vaccines and Therapeutics The present Competitive Intelligence Report about RSV Vaccines & Therapeutics provides a ... RSV disease in infants and children at high risk for severe lung disease from RSV, a RSV vaccine still is not on the market. A number ...

The present Competitive Intelligence Report about Pseudomonas aeruginosa Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies, peptides and small molecules as well as DNA-, RNA- and microorganism-based therapies against infection with ...

The research object of the report is human vaccine apart from animal vaccine. Vaccination is the most economical, effective, safe and convenient way to prevent disease and the investment of vaccinatio...

Influenza Vaccine Market Overview Last few years have seen renewed interest in the vaccines market, overcoming the prevailing view that vaccines are a low-margin business with high barriers...

Subscription to La Merie’s proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use ...

... (plasmid, conventional, alternative delivery and prime – boost regimens) Adenoviral vector vaccines Poxvirus vector vaccines Protein & peptide vaccines Others Corporate HIV Vaccine R&D Pipelines About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise ...

... Vaccines Combination Vaccines including HAV Vaccines Combination Vaccines including HBV Vaccines Hepatitis C Virus Vaccines Hepatitis E Virus Vaccines Corporate Hepatitis Vaccine Product Portfolios and R&D Pipelines About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but ...

... of seasonal and pandemic influenza disease. In addition, the report lists company-specific product portfolios and R&D pipelines of influenza vaccines on the market and in R&D. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of ...

For decades vaccines were a neglected corner of the drugs business, with old technology, little investment and abysmal profit margins. Many firms sold their vaccine divisions to concentrate on more pr...

FMD is the first animal virus recognized by human beings. FMD occurs and prevails in most countries in the world, except for few countries with favorable conditions of natural separation. Office Inter...

The common animal vaccines at present are mainly applied in such mammals as pigs, cattle, sheep and bird species. In fact, fish and other aquatic products are also in demand for vaccines. In 2009, th...